Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)

Jair Bar*, Maya Damianovich, Goni Hout Siloni, Erel Dar, Yehudit Cohen, Oranit Zadok, Yoram Cohen, Marina Perelman, Iris Barshack, Ronit I. Yarden, David Simansky, Alon Ben Nun, Amir Onn

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology